Health CarePharmaceuticals & Biotechnology
  • Price (GBX)333.30
  • Today's Change-6.70 / -1.97%
  • Shares traded377.00
  • 1 Year change-36.76%
  • Beta1.3825
Data delayed at least 20 minutes, as of Dec 16 2019 08:34 GMT.
More ▼

Key statistics

As of last trade, Hutchison China MediTech Ltd (HCM:LSE) traded at 333.30, 27.95% above the 52 week low of 260.50 set on Oct 14, 2019.
52-week range
260.50Oct 14 2019529.50Dec 17 2018
Markit short selling activity
Previous close340.00
Average volume83.36k
Shares outstanding666.89m
Free float302.21m
P/E (TTM)--
Market cap2.24bn GBP
EPS (TTM)-0.0987
Data delayed at least 20 minutes, as of Dec 16 2019 08:34 GMT.
More ▼

Investors Chronicle View

The last IC recommendation on Hutchison China MediTech Ltd shares was Buy at 292.00 on 03 Oct 2019Read the full article
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.